Clinical Trial

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main objective of this trial was to determine the value of concurrent chemoradiotherapy for Intermediate-risk head and neck squamous cell carcinoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-10.
Status change: Not Yet Recruiting → Recruiting 2026-03-20
Trial Details
NCT Number NCT07125755
Lead Sponsor Sun Yat-sen University
Conditions Squamous Cell Cancer of Head and Neck (SCCHN)
Enrollment 386 participants
Start Date 2025-08-15
Primary Completion 2028-08-15 (estimated)
Study Completion 2031-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-23